News

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are ...
During a severe heart attack many heart muscle cells die and are replaced by scar tissue to stabilize the heart wall.
This week on "The Readout LOUD" podcast, a mother whose son has Duchenne muscular dystrophy shares her perspective on Sarepta ...
Sarepta Therapeutics (SRPT) stock drops as the company faces potential FDA-mandated studies after safety concerns over its ...
Rocket Pharmaceuticals will cut 80 jobs and streamline operations, focusing on gene therapies to drive long-term growth.
The UK’s drugs regulator has introduced new regulations that will enable hospitals to perform the final manufacturing steps of personalised gene therapy treatments. The Medicines and Healthcare ...
Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...
Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.
Sarepta stock plunged again Thursday on a report the FDA will require additional clinical testing to validate the safety ...
This Massachusetts-based biopharmaceutical company announced hundreds of layoffs last week. Here's what the CEO said about it ...
Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope ...
To explain genomics in simple terms and its importance, genetics as a scientific field comes from the work of Gregor Mendel in the 19th century. The term 'Genetics' was introduced by English biologist ...